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The Toxicity of the Aggregatibacter Actinomycetemcomitans Cytolethal
Distending Toxin Correlates With its Phosphatidylinositol-3,4,5-Triphosphate
Phosphatase Activity
Abstract
The Aggregatibacter actinomycetemcomitans cytolethal distending toxin (Cdt) induces G2 arrest and
apoptosis in lymphocytes and other cell types. We have shown that the active subunit, CdtB, exhibits
phosphatidylinositol-3,4,5-triphosphate (PIP3) phosphatase activity, leading us to propose that Cdt
toxicity is the result of PIP3 depletion and perturbation of phosphatidylinositol-3-kinase (PI-3K)/PIP3/Akt
signalling. To further explore this relationship, we have focused our analysis on identifying residues that
comprise the catalytic pocket and are critical to substrate binding rather than catalysis. In this context, we
have generated several CdtB mutants and demonstrate that, in each instance, the ability of the toxin to
induce cell cycle arrest correlates with retention of phosphatase activity. We have also assessed the
effect of Cdt on downstream components of the PI-3K signalling pathway. In addition to depletion of
intracellular concentrations of PIP3, toxin-treated lymphocytes exhibit decreases in pAkt and pGSK3β.
Further analysis indicates that toxin-treated cells exhibit a concomitant loss in Akt activity and increase in
GSK3β kinase activity consistent with observed changes in their phosphorylation status. We demonstrate
that cell susceptibility to Cdt is dependent upon dephosphorylation and concomitant activation of GSK3β.
Finally, we demonstrate that, in addition to lymphocytes, HeLa cells exposed to a CdtB mutant that retains
phosphatase activity and not DNase activity undergo G2 arrest in the absence of H2AX phosphorylation.
Our results provide further insight into the mode of action by which Cdt may function as an immunotoxin
and induce cell cycle arrest in target cells such as lymphocytes. © 2016 John Wiley & Sons Ltd.

Disciplines
Dentistry

Author(s)
Bruce J. Shenker, Kathleen Boesze-Battaglia, Monika Damek Scuron, Lisa P. Walker, Ali Zekavat, and
Mensur Dlakić

This journal article is available at ScholarlyCommons: https://repository.upenn.edu/dental_papers/396

doi:10.1111/cmi.12497
First published online 2 September 2015

The toxicity of the Aggregatibacter
actinomycetemcomitans cytolethal distending toxin
correlates with its phosphatidylinositol-3,4,5triphosphate phosphatase activity
Bruce J. Shenker,1* Kathleen Boesze-Battaglia,2
Monika Damek Scuron,1 Lisa P Walker,1
Ali Zekavat1 and Mensur Dlakić3
1
Department of Pathology, University of Pennsylvania
School of Dental Medicine, Philadelphia, PA, USA.
2
Department of Biochemistry, University of Pennsylvania
School of Dental Medicine, Philadelphia, PA, USA.
3
Department of Microbiology and Immunology, Montana
State University, Bozeman, MT, USA.

phorylation and concomitant activation of GSK3β.
Finally, we demonstrate that, in addition to
lymphocytes, HeLa cells exposed to a CdtB
mutant that retains phosphatase activity and not
DNase activity undergo G2 arrest in the absence
of H2AX phosphorylation. Our results provide
further insight into the mode of action by which
Cdt may function as an immunotoxin and induce
cell cycle arrest in target cells such as lymphocytes.

Summary
The Aggregatibacter actinomycetemcomitans
cytolethal distending toxin (Cdt) induces G2 arrest
and apoptosis in lymphocytes and other cell types.
We have shown that the active subunit, CdtB,
exhibits phosphatidylinositol-3,4,5-triphosphate
(PIP3) phosphatase activity, leading us to propose
that Cdt toxicity is the result of PIP3 depletion and
perturbation of phosphatidylinositol-3-kinase (PI3K)/PIP3/Akt signalling. To further explore this
relationship, we have focused our analysis on
identifying residues that comprise the catalytic
pocket and are critical to substrate binding rather
than catalysis. In this context, we have generated
several CdtB mutants and demonstrate that, in
each instance, the ability of the toxin to induce cell
cycle arrest correlates with retention of phosphatase activity. We have also assessed the effect of
Cdt on downstream components of the PI-3K
signalling pathway. In addition to depletion of
intracellular concentrations of PIP3, toxin-treated
lymphocytes exhibit decreases in pAkt and
pGSK3β. Further analysis indicates that toxintreated cells exhibit a concomitant loss in Akt
activity and increase in GSK3β kinase activity
consistent with observed changes in their phosphorylation status. We demonstrate that cell
susceptibility to Cdt is dependent upon dephos-
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Introduction
Over the past several years, lipids in general, and
phosphatidylinositol-3,4,5-triphosphate (PIP3) in particular,
have become recognized for their central role in regulating
an array of biological responses; these include cell growth,
proliferation and survival, among others (Kraub and
Haucke, 2007; Sasaki et al., 2007; Buckler et al., 2008;
Huang and Sauer, 2010). PIP3 is normally maintained at low
intracellular levels and increases rapidly in response to a
variety of signals that involve plasma membrane recruitment and activation of phosphatidylinositol-3-kinase (PI3K). Normal cell function requires that PIP3 levels be tightly
regulated; three degradative enzymes, PTEN, SHIP1 and
SHIP2, have been shown to play critical roles in this capacity
(Krystal, 2000; March and Ravichandran, 2002; Seminario
and Wange, 2003). The tumour suppressor phosphatase,
PTEN (ptase and tensin homolog deleted on chromosome
ten), hydrolyses PIP3 to phosphatidylinositol-4,5-biphosphate
(PI-4,5-P2). SHIP1 (src homology 2-containing inositol
ihosphatase) and SHIP2 are inositol 5-phosphatases
(IP5P); whereas SHIP2 is ubiquitously expressed, SHIP1
appears to be found in a limited subset of cells including
most immune cells. Both SHIP enzymes hydrolyse PIP3
to phosphatidylinositol-3,4-biphosphate (PI-3,4P2) and
inositol 1,3,4,5-tetrakisphosphate to inositol 1,3,4triphosphate. Collectively, these enzymes contribute to
regulation of the PI-3K/PIP3/Akt signalling pathway.
Over the course of our investigations, we have demonstrated that Aggregatibacter actinomycetemcomitans, a

© 2015 John Wiley & Sons Ltd,
© 2015 John Wiley & Sons Ltd
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putative pathogen implicated in the aetiology and pathogenesis of localized juvenile periodontitis, produces an
immunotoxin that affects human T cells (Shenker et al.,
1982b; 1990; 1999). This toxin was shown to interfere with
normal cell cycle progression, resulting in G2 arrest as well
as inducing apoptosis (Shenker et al., 1995). Moreover, we
have shown that the active toxin is the product of the
cytolethal distending toxin (Cdt) operon (Shenker et al.,
1999). Cdts are a family of heat-labile protein cytotoxins
produced by several different bacterial species including
Campylobacter jejuni, Shigella species, Haemophilus
ducreyi, A. actinomycetemcomitans and diarrhoeal
disease-causing enteropathogens such as some
Escherichia coli isolates (Scott and Kaper, 1994; Okuda
et al., 1995; Pickett et al., 1996; Comayras et al., 1997;
Mayer et al., 1999; Shenker et al., 1999). The Cdt operon
contains three genes, cdtA, cdtB and cdtC, which specify
three polypeptides with molecular masses of 18, 32 and
20 kDa respectively. Cdt holotoxin functions as an AB2
toxin, where subunits CdtA and CdtC comprise the binding
(B) unit and CdtB the active subunit. Moreover, CdtC binds
to the plasma membrane of cells via cholesterol in the
context of lipid rafts (Boesze-Battaglia et al., 2009). It
should also be pointed out that Carette et al. (2009)
demonstrated that cell mutants lacking sphingomyelin
synthase are resistant to CdtB. These results suggest that
CdtB may be involved in lipid metabolism as lipid rafts and
sphingomyelin-controlled protein scaffolds are important
for lipid signalling in cells: either lipid rafts are important for
CdtB entry into cells, or lipid raft integrity is necessary for
CdtB function once inside of the cell. Thus, it is particularly
noteworthy that we recently demonstrated that CdtB is
capable of hydrolysing PIP3 and appears to function as an
IP5P similar to the SHIP enzymes (Shenker et al., 2007).
Hence, as lipid rafts often serve as signalling platforms, we
predict that CdtB is endocytosed into the cell, allowing it to
access the cytoplasmic face of the cell membrane and to
PIP3 pools.
Our studies have led us to propose that CdtB-induced
cell cycle arrest and apoptosis is the result of PIP3
depletion and perturbation of the PI-3K/PIP3/Akt signalling
cascade. The relationship between CdtB and SHIP is not
surprising because the initial observations of Dlakic (2001)
indicate sequence and structural homology between CdtB
and a larger group of divergent enzymes that include
IP5P. These enzymes have been predicted, based on
structural analysis, to be similar in fold and mechanism to
DNase I and related metal-dependent phosphohydrolases
(Drayer et al., 1996; Mitchell et al., 1996; Woscholski and
Parker, 1997; Majerus et al., 1999; Tsujishita et al., 2001).
To further explore this relationship and the role of PIP3
phosphatase activity in Cdt-mediated toxicity, we have
extended our investigation to an analysis of the amino
acid residues that comprise the catalytic pocket and that

contribute to substrate binding. Furthermore, we now
demonstrate that Cdt-treated lymphocytes exhibit alterations in the PI-3K signalling cascade consistent with the
action of the toxin acting as an IP5P. Finally, we
demonstrate a relationship between activation of GSK3β,
PIP3 content and susceptibility to Cdt-induced G2 arrest.
Results
Analysis of CdtB substrate binding mutants
Based on sequence and structural comparisons, it has
been proposed that the active Cdt subunit, CdtB, shares
catalytic residues and a similar reaction mechanism with a
large group of functionally diverse Mg2+-dependent
phosphoesterases (Dlakic, 2000). DNase I was the first
structurally characterized member of this enzyme superfamily (Lahm and Suck, 1991); subsequent structural
characterization of IP5P and CdtB confirmed the initial
prediction (Tsujishita et al., 2001; Nesic et al., 2004;
Yamada et al., 2006). An alignment of these three
structures shows striking conservation of catalytic and
divalent ion-chelating residues, despite low overall sequence identity (Fig. 1A). As a general rule, all enzymes in
this superfamily use the same catalytic residues to
hydrolyse phosphate esters, and their specific function is
determined by additional, non-catalytic residues that line
up the active site and recognize the correct substrate(s).
Thus, these additional residues allow for substrate
specificity even though other substrates sometimes can
be accommodated, albeit with lower affinity, and are
usually converted with considerably lower activity. CdtB
appears to be an enzyme with strong PIP3 phosphatase
activity and weak DNase activity (Shenker et al., 2007),
which implies that PIP3 is its primary substrate; in this
scenario, DNA would be an incidental substrate that can
be acted upon only with much lower activity.
Our previous studies focused on mutating catalytic
residues (Shenker et al., 2007); however, this approach
did not give a clear answer as to whether CdtB is primarily
a phosphatase or a nuclease because both activities are
likely to be abolished. Instead, mutations targeting
substrate binding and other non-catalytic functions of the
protein are likely to provide clear distinction between the
two possible activities. Therefore, we generated several
CdtB mutants that involve amino acid substitutions in
residues that correspond to the putative active site and
likely to be involved in substrate binding (Table 1); these
residues are R117, R144 and A163. Docking analysis
using IP3 as a substrate raised the possibility that R117
interacts with C3 phosphate of IP3 and that R144 forms a
hydrogen bond with either the C4 or C5 phosphate; we
predicted that mutations of either of these two arginines to
alanine would reduce phosphatase activity while possibly
not compromising DNase activity (Figs. S1 and S2). A163
© 2015 John Wiley & Sons Ltd, Cellular Microbiology, 18, 223–243
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Fig. 1. Analysis of CdtB mutants for PIP3 phosphatase, DNase and toxic activities. Panel A shows the structural alignment of CdtB (PDB code
2f2f_B, accession number Q7DK12), inositol polyphosphate 5-phosphatase (IP5P) (PDB code 1i9y_A, accession number O43001) and DNase I
(PDB code 2dnj_A, accession P00639), which was obtained by MUSTANG and modified by hand after visual inspection of structures. Numbering in
the alignment refers to full-length proteins. The consensus line indicates the conservation of small (s), aliphatic (l), hydrophobic (h), charged (c),
positive (+) and negative ( ) residues, while identical residues are shown as capital letters. Numbers in parentheses within the alignment indicate
how many residues were omitted either because of long insertions not shared by all proteins or because structures could not be reliably aligned in
those regions. Amino acids mutated in this study were divided into three groups: residues predicted to be involved in substrate binding (marked by
green diamonds above the alignment), residues near the catalytic H160 that are conserved in CdtB and IP5P but not DNase I (red triangles pointing
down) and residues near the catalytic D238 that are conserved in IP5P and DNase I but not CdtB (blue triangles pointing up). The catalytic N201 is
marked by a green dot because in some experiments it was combined with binding mutants. Each mutant was analysed for PIP3 phosphatase
activity (panel B), DNase activity (panel B) and the ability to induce G2 arrest in Jurkat cells (panel C). PIP3 phosphatase activity was assessed in
the presence of 0.25 μM and is expressed as nanomolar phosphate release from PIP3 per 30 min. DNase activity was assessed as described in
WT
Materials and methods; numbers represent the % control (CdtB ) as mean ± SEM of each mutant to convert supercoiled plasmid DNA to the
relaxed form. The ability of the mutants to induce G2 arrest is described in Experimental procedures section (Shenker et al., 2005). The percentage
of G2 cells is plotted versus CdtB concentration; cells exposed to medium exhibited 14% G2 cells. Results are the mean ± SEM of three
WT
experiments. The asterisk indicates statistical significance (p < 0.05) when compared with CdtB .

was chosen because it interacted differently with IP3 and
IP2 based on docking experiments, and we wanted to
assess its role in substrate binding specificity. The R117
and R144 mutants were already tested for DNase (Nesic
© 2015 John Wiley & Sons Ltd, Cellular Microbiology, 18, 223–243

et al., 2004), but not phosphatase activity; we decided to
include them for comparison. Likewise, we included
another residue, N201, which is associated with the
catalytic site and is conserved in all three proteins (Fig. 1A);
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Table 1. CdtB mutant constructs.
Plasmid

Primer

pGEMCdtB

R117A

pGEMCdtB

R144A

pGEMCdtB

A163R

pGEMCdtB

N201A

pGEMCdtB

R117A•R144A•N201A

pGEMCdtB

F156I•T158A•A163R

pGEMCdtB

Y239R

pGEMCdtB

Y239R•A240I•D244G•H246L

a

P1
P2
P3
P4
P5
P6
P7
P8
P9
P10
P11
P12
P13
P14
P15
P16
P17
P18

Sequencea
GATGTTGGGGCAAACGCAGTGAACTTAGCTATCG
CGATAGCTAAGTTCACTGCGTTTGCCCCAACATC
CTGTGCTTCAATCTGCCCCGGCAGTAGGTATCC
GGATACCTACTGCCGGGGCAGATTGAAGCACAG
CAGTGCATGCTTTGAACACAGGTGGTTCTGATGCGG
CCGCATCAGAACCACCTGTGTTCAAAGCATGCACTG
GGATGGTTGTTGGTGATTTCGCTCGTGCGCCGG
CCGGCGCACGAGCGAAATCACCAACAACCATCC
CTGTGCTTCAATCTGCCCCGGCAGTAGGTATCC
GGATACCTACTGCCGGGGCAGATTGAAGCACAG
CGCATTGGTACTGATGTAATTTTTGCAGTGCATGCTTTG
CAAAGCATGCACTGCAAAAATTACATCAGTACCAATGCG
CGGTCCGGTAATATTTTAGATCGTGCGATTTTACATGACGCAC
GTGCGTCATGTAAAATCGCACGATCTAAAATATTACCGGACCG
CGGTCCGGTAATATTTTAGATCGTATCATTTTACATGACGCAC
GTGCGTCATGTAAAATGATACGATCTAAAATATTACCGGACCG
ATCATTTTACATGGCGCACTTTTACCACGTCGA
TCGACGTGGTAAAAGTGCGCCATGTAAAATGAT

Bold letters in the sequence indicate nucleotide substitutions.

docking analysis demonstrated close proximity of this
residue to inositol within the substrate.
We constructed plasmids that express the following
CdtB mutants: CdtB R117A , CdtB R144A , CdtB A163R ,
CdtBN201A and the triple mutant CdtBR117A•R144A•N201A.
Mutants were first assessed for PIP3 phosphatase activity
(Fig. 1B). Although the CdtB R117A, CdtBR144A and
CdtBR117A•R144A•N201A mutants exhibited detectable levels
of phosphatase activity, the values were significantly
below that observed with CdtBWT (0.77 ± 0.10 nM of
phosphate release per 30 min); CdtBN201A exhibited
phosphatase activity that was higher than the other three
mutants (0.28 ± 0.06 nM of phosphate release per 30 min)
but also statistically lower than that observed for the wildtype protein. In contrast, CdtBA163R exhibited phosphatase
activity that was reduced relative to CdtBWT (0.43 ±
0.05 nM of phosphate release per 30 min); however, this
difference was not statistically different from that observed
for the CdtBWT. Additionally, the mutants were analysed
for DNase activity (Fig. 1B). Relative to CdtBWT (100%),
DNase activity exhibited by CdtBR117A was increased
slightly (117 ± 14% of wild type) while CdtBR144A and
CdtBR117A•R144A•N201A exhibited increased activity to
465 ± 54% and 318 ± 44 %, respectively, of the activity
observed with CdtBWT. In contrast, CdtBN201A and
CdtBA163R did not exhibit detectable DNase activity. It is
noteworthy that CdtBA163R is the first non-catalytic mutant
that retains most of the PIP3 phosphatase activity while
being unable to cleave DNA. Finally, CdtB mutants were
assessed for their ability to induce cell cycle arrest
(Fig. 1C). It should be noted that, as previously reported,
the ability of CdtB to induce G2 arrest requires the
presence of CdtA and CdtC (Shenker et al., 2004; 2005).
Thus, these experiments were performed in the presence

of CdtA and CdtC under conditions that we have
previously demonstrated to result in an active toxin
complex. CdtBA163R retained toxic activity as exposure
to 6 and 40 ng ml 1 of the mutant resulted in 23 ± 1.3%
and 41.3 ± 1.6% G2 cells; this compares with the effect of
CdtBWT at 0.32 (24.6 ± 1.3% G2 cells) and 1.6 ng ml 1
(41.5 ± 1.7% G2 cells). Untreated control cells exhibited
14% G2 cells. In contrast, CdtBN201A induced 17.9 ± 0.8
and 32.9 ± 1.1% G2 cells at 40 and 200 ng ml 1 of mutant
protein respectively. It should be noted that the other two
CdtB mutants failed to exhibit the ability to induce cell
cycle arrest in Jurkat cells at concentrations tested (up to
1 μg ml 1).
Analysis of CdtB mutants close to the active sites of CdtB,
IP5P and DNase
Alignment of CdtB, IP5P and DNase I demonstrates a
number of residues that are conserved in two out of the
three proteins (Fig. 1A). We first focused on regions close
to catalytic residues that are conserved in both CdtB and
IP5P; these residues were mutated to the residues found
in DNase I. A plasmid was constructed that expressed a
protein with three residues modiﬁed, CdtBF156I•T158A•A163R;
PIP3 phosphatase activity of this mutant was significantly
reduced to 0.31 ± 0.03 nM of phosphate release per 30 min
compared with 0.77 ± 0.1 nM of phosphate release for
CdtBWT (Fig. 1B). In contrast, this mutant exhibited
increased DNase activity to 374 ± 34% of control values
(Fig. 1B). CdtBF156I•T158A•A163R was unable to induce G2
arrest at any concentrations tested (Fig. 1C). It should be
noted that an additional construct expressing
CdtBF156I•T158A exhibited similar properties as the triple
mutant. Next, two additional plasmids were constructed to
express CdtB mutants that target residues conserved in
© 2015 John Wiley & Sons Ltd, Cellular Microbiology, 18, 223–243
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both DNase I and IP5P; we mutated these residues to
match DNase I residues at those positions. These mutants
include CdtBY239R and CdtBY239R•A240I•D244G•H246L; both
mutants demonstrated significantly reduced PIP3 phosphatase activity: 0.19 ± 0.03 (CdtBY239R) and 0.32 ± 0.03
(CdtBY239R•A240I•D244G•H246L) (Fig. 1B). Figure 1B also
shows the results of DNase analysis for these mutants;
CdtBY239R exhibited nuclease activity comparable with
CdtBWT (137 ± 64%) while CdtBY239R•A240I•D244G•H246L
exhibited an increase in nuclease activity (180 ± 61%).
Analysis of the ability of the mutants to induce G2 arrest in
Jurkat cells (Fig. 1C) indicates that CdtBY239R and
CdtBY239R•A240I•D244G•H246L were unable to induce cell
cycle arrest at any concentration tested. Therefore,
mutants that disrupt phosphatase activity of CdtB also
disrupt its cytotoxic properties, even when the nuclease
activity of those same mutants is improved or unaffected.
Effect of Cdt on downstream PI-3K signalling
In order to further define the role for lipid phosphatase
activity in Cdt-mediated toxicity, we first demonstrate that
the toxin is indeed capable of altering intracellular levels of
substrate and product, PIP3 and PI-3,4P2, respectively, in
both the Jurkat cell line and in primary lymphocytes
activated with mitogen. As shown in Fig. 2A, Jurkat cells
treated with Cdt exhibited a dose-dependent decrease in
PIP3. Baseline levels of PIP3 in untreated cells were 3.7 ±
1.0 pmol per 106 cells. In contrast, cells treated with
50 pg ml 1 of Cdt for 1 h exhibited a reduction to 2.7 ±
0.5 pmol per 106 cells; PIP3 levels further declined to 1.4 ±
0.3 and 0.8 ± 0.4 pmol per 106 cells in the presence of 500
and 5000 pg ml 1 of Cdt. The decrease in PIP3 was also
time dependent (Fig. 2B); a 21% reduction was observed
within 30 min in cells exposed to 50 pg ml 1 of Cdt (2.6 ±
0.5 pmol per 106 cells) versus that observed in control
cells (3.3 ± 0.3 pmol per 106 cells). PIP3 levels continued
to decline over time (30–120 min) with levels reduced by
42% (60 min) and 61% (120 min). Toxin-treated Jurkat
cells were also assessed for changes in the enzymatic
product of Cdt-mediated PIP3 de-phosphorylation, PI3,4P2. Cdt (50 pg ml 1) caused a time-dependent increase in the intracellular levels of PI-3,4P2 (Fig. 2B).
Cells exhibited a 28% increase in the phosphatidylinositoldiphosphate within 30 min of exposure to toxin (0.84 ±
0.06 pmol per 106 cells) over that observed in control cells
(0.65 ± 0.06 pmol per 106 cells). Intracellular levels of PI3,4P2 continued to increase over time (30–120 min),
reaching a more than threefold increase at 120 min (2.1 ±
0.1 pmol per 106 cells). The increase in PI-3,4P2 was
specific as intracellular concentrations of PI-4,5-P2 were
not altered (Fig. 2B).
Mitogenic stimulation of human peripheral blood mononuclear cells (HPBMC) is known to lead to activation of the
PI-3K signalling cascade and a rapid rise in PIP3 levels
© 2015 John Wiley & Sons Ltd, Cellular Microbiology, 18, 223–243
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(Liscovitch and Cantley, 1992; Coers et al., 1995; Cantley
and Neel, 1999; Buckler et al., 2008; Huang and Sauer,
2010). We have previously shown that Cdt is capable of
inhibiting mitogen-induced proliferation of HPBMC
(Shenker et al., 2000). Therefore, we determined if Cdt
was able to prevent this mitogen-induced increase in
PIP3. HPBMC were pre-treated with Cdt (or medium) for
60 min and then stimulated with phytohaemagglutinin
(PHA) (Fig. 2C). Cells were then assessed for PIP3 levels
at varying time intervals (0–120 min). Control HPBMC
incubated for 60 min with PHA exhibited a 44% increase in
PIP3 (Fig. 2C); these concentrations remained elevated
for at least 2 h. In contrast, HPBMC pre-treated with Cdt
failed to exhibit an increase in PIP3, and instead, PIP3
levels were reduced 40% and 60% at 60 and 120 min
respectively. Similar results were observed with cells
activated with anti-CD3 and anti-CD28 monoclonal antibodies (data not shown).
The PI-3K signalling pathway controls cellular functions
via the activation of protein kinases and the downstream
phosphorylation of multiple substrates. In the next series
of experiments, we focused on the effect of Cdt on the
downstream targets of PIP3: Akt and GSK3β. Jurkat cells
were treated with 200 pg ml 1 of Cdt for 0–4 h, and the
levels of Akt, pAkt, GSK3β and pGSK3β analysed by
Western blot. As shown in Fig. 2D and E, Akt phosphorylation (S473) was reduced to 63 ± 12.3% of control
values at 1 h and significantly reduced to 48.7 ± 9.3%
and 45.5 ± 11.6% of control values at 2 and 4 h respectively. Akt levels were not significantly altered at any time
point. Additionally, pGSK3β (S9) was reduced to 65.3 ±
15.1% of control levels at 1 h and significantly reduced to
55.7 ± 6.0% and 47.6 ± 6.1% of control values at 2 and 4 h
respectively. No significant changes in GSK3β levels were
observed during the 4 h of exposure to Cdt. Similarly, Cdt
was able to block the mitogen (PHA)-induced increase in
pGSK3β that occurs upon HPBMC activation. As shown in
Fig. S3, PHA increased pGSK3β to 146% of that observed
in untreated control cells; exposure to 50, 250 and
1000 pg ml 1 Cdt reduced pGSK3β to 123%, 80% and
34% of that observed in control cells respectively. In order
to obtain information on changes in pAkt and pGSK3β in
individual cells, we extended our studies to include
analysis by immunofluorescence and flow cytometry. As
shown in Fig. 3, Jurkat cells treated with Cdt exhibit a
dose-dependent reduction in the percentage of cells
containing detectable pAkt (S473); values ranged from
82% in control cells down to 21% in cells exposed to
10 ng ml 1 of Cdt. Flow cytometric analysis of pGSK3β
also indicates a dose-dependent reduction in the percentage of cells containing the phosphorylated kinase; values
ranged from 78% positive cells in the control population to
55% (0.1 ng ml 1 of Cdt), 34% (1.0 ng ml 1 of Cdt) and
12% (10.0 ng ml 1 of Cdt).
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Fig. 2. Effect of Cdt on PI-3K signalling in Jurkat cells and HPBMC. Jurkat cells were exposed to Cdt holotoxin as indicated, harvested, PIs
extracted and measured by enzyme-linked immunosorbent assay. Panel A shows the effect of varying amounts of Cdt on Jurkat cells after 1 h of
1
exposure. Jurkat cells were also exposed to Cdt (50 pg ml ) for varying time periods (panel B); levels of PIP3 (diamonds), PI-3,4P2 (circles) and PI1
4,5-P2 (triangles) are plotted. Panel C shows the results for HPBMC pre-incubated in medium (solid circles) or with Cdt (open circles; 50 pg ml ) for
6
1 h. HPBMC were then activated for varying periods of time in the presence of PHA. Results are plotted as picomole PIP3 or PIP2 per 10 cells; data
represent the mean ± SEM for three experiments. The asterisk indicates statistical significance (p < 0.05) when compared with untreated control
(panels A and B) and to PHA control (panel C). Panel D shows a representative Western blot of the effect of Cdt on Akt and GSK3β phosphorylation.
1
Jurkat cells were treated with Cdt (200 pg ml ) for 2 h and then analysed by Western blot for pAkt (S473), Akt, pGSK3β (S9), GSK3β and GAPDH
as a loading control. Panel E: Blots from three experiments were analysed by scanning densitometry and are expressed as a percentage of the
relative intensity of untreated control cells; mean ± SEM for three experiments are plotted. The asterisk indicates statistical significance (p < 0.05)
when compared with untreated control cells.
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panels) in individual cells is shown. Cells were treated with Cdt holotoxin (0–10 ng ml ) and analysed by flow cytometry following
immunofluorescence staining. Bars indicate the analysis gate for positively stained cells; the percentage of positive cells as well as their mean
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In addition to Western blot and flow cytometric analysis
of the phosphorylation status of Akt and GSK3β, we also
assessed Cdt-treated Jurkat cells (4 h) for both Akt and
GSK3β kinase activity. The active form of Akt (pAkt) was
isolated from cell extracts by immunoprecipitation and
activity assessed by monitoring phosphorylation of GSK.
As shown in Fig. 4A, Akt obtained from Cdt-treated cells
exhibited reductions in kinase activity relative to control
© 2015 John Wiley & Sons Ltd, Cellular Microbiology, 18, 223–243

cells: 65 ± 11% (0.1 ng ml 1 of Cdt), 63 ± 18% (1.0 ng ml 1
of Cdt) and 45 ± 13% (10 ng ml 1 of Cdt). Likewise, GSK3β
was isolated by immunoprecipitation and then monitored
for kinase activity by utilizing labelled ATP to measure 32P
incorporation into a synthetic substrate. Cells exposed to
toxin exhibited a dose-dependent increase in GSK3β
kinase activity (Fig. 4B); activity increased from 57%
(0.1 ng ml 1 of Cdt) to 206% above control levels
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Fig. 4. Effect of Cdt on Akt and GSK3β kinase activity. Jurkat cells
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were treated with 0.1, 1.0 and 10 ng ml of Cdt holotoxin for 4 h.
Panel A shows Akt kinase activity following pAkt immunoprecipitation
from solubilized cells. Akt kinase activity was measured by monitoring
GSK3β phosphorylation in vitro; results are expressed as a
percentage of control, and the mean ± SEM are plotted. GSK3β
kinase activity was measured in similarly treated cells followed by
immunoprecipitation of the kinase; GSK3β activity was determined by
32
monitoring the utilization of P-ATP to phosphorylate a synthetic
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substrate. Data are plotted as P (cpm) incorporation versus Cdt
concentration; results represent the mean ± SEM for three
experiments. The asterisk indicates statistical significance (p < 0.05)
when compared with untreated control cells.

(10 ng ml 1 of Cdt). In order to determine if the Cdtinduced increase in GSK3β activity was required for the
toxin to induce cell cycle arrest, we employed four cell
permeable inhibitors of the kinase. As shown in Fig. 5,
Jurkat cells treated with Cdt alone (50 pg ml 1) exhibited
an increase in the percentage of G2 cells to 58% while
untreated cells contained 19% G2 cells. Each of the
GSK3β inhibitors reduced the percentage of G2 cells in
the presence of Cdt: 29% (LiCl), 25% (GSK inhibitor X),
25% (GSK inhibitor XII) and 15% (GSK inhibitor XV). In
addition to Jurkat cells, the GSK inhibitor X prevented Cdtinduced G2 arrest in PHA-activated HPBMC (Fig. S4).
Several investigators have proposed that Cdt-mediated
toxicity in non-lymphoid cells is the direct result of DNA
damage resulting from DNase activity associated with

CdtB, leading to activation of the DNA damage response
(DDR) (Cortes-Bratti et al., 2001a; Frisan et al., 2002; Li
et al., 2002; Hassane et al., 2005). To address these
disparate findings and determine if the DDR plays a role in
Cdt-induced cell cycle arrest in lymphocytes, we employed
two Ataxia telangiectasia mutated (ATM) inhibitors:
KU60019 and KU55933. Because we previously demonstrated that H2AX phosphorylation was not directly due to
the action of Cdt in Jurkat cells (Shenker et al., 2006), we
chose to utilize a different lymphoid cell line for these
experiments, CCRF-CEM, an acute lymphoblastic leukaemia cell line. CCRF-CEM cells were exposed to
200 pg ml 1 of Cdt, a dose optimized for G2 arrest. As
shown in Fig. 6I, this dose of Cdt resulted in 42.0 ± 1.1% G2
cells after 16 h; this compares with 16.0 ± 2.6% in control
(untreated) cells. Neither of the inhibitors had an effect on
Cdt-induced G2 arrest; the percentage of G2 cells was
39.1 ± 2.3% and 40.9 ± 0.1% in cells pre-treated with 10 μM
of KU60019 or 10 μM of KU55933, respectively, and then
exposed to toxin. These results are consistent with our
failure to detect an effect of Cdt on pH2AX as the mean
channel fluorescence (MCF) of CCRF-CEM cells stained
with anti-pH2AX antibody conjugated to fluorescein isothiocyanate and analysed by flow cytometry was unchanged in the presence of toxin relative to control values
(Fig. 6A–D). To verify the validity of our approach and the
effectiveness of the ATM inhibitors, CCRF-CEM cells were
similarly treated with etoposide. In contrast to Cdt,
treatment with 0.5 μM of etoposide induced pH2AX staining
as these cells exhibited an MCF of 213 vs 38 in control cells.
As shown in Fig. 6E–H, the ATM inhibitors reduced pH2AX
to an MCF of 147 (KU60019) and 150 (KU55933).
Moreover, etoposide alone resulted in G2 arrest (45 ±
3.9%); cell cycle arrest was reduced to 29.8 ± 6.8 and
28.1 ± 2.6% G2 cells in the presence of KU60019 and
KU55933 respectively (Fig. 6I).
The failure of Cdt to induce phosphorylation of H2AX in
CCRF-CEM cells and the inability of ATM kinase inhibitors
to block toxin-induced cell cycle arrest are consistent with a
Cdt mode of action involving PI-3K signalling blockade and
inconsistent with a mechanism involving activation of the
DDR. To determine if non-lymphoid cells were affected in a
similar fashion, we assessed and compared CdtBWT with
CdtBA163R, the mutant that retained phosphatase and toxic
activities and that lost DNase activity, and CdtBR144A, the
mutant that lost phosphatase and toxic activities but
exhibited an increase in DNase activity, for their ability to
both induce G2 arrest and H2AX phosphorylation in a
commonly used experimental Cdt target, HeLa cells. As
shown in Fig. 7A–D and I, treatment of HeLa cells for 24 h
with 25 ng ml 1 of either CdtBWT or CdtBA163R (in the
presence of CdtA and CdtC subunits as described) resulted
in 77.1 ± 11.0% and 75.6 ± 11.7% G2 cells. In contrast,
control cells and HeLa cells treated with CdtBR144A
© 2015 John Wiley & Sons Ltd, Cellular Microbiology, 18, 223–243
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Fig. 5. Effect of GSK3β inhibitors on Cdt-induced cell cycle arrest. Jurkat cells were pre-treated with medium, LiCl, GSK inhibitor X, XI or XV for 1 h
1
followed by the addition of Cdt holotoxin (50 pg ml ). Sixteen hours later, the cells were harvested, stained with propidium iodide and analysed for
cell cycle distribution by flow cytometry. Representative results of three experiments are shown: cells only (A), Cdt alone (B), LiCl and Cdt (C), GSK
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exhibited 12.9±3.1% and 17.5±1.3% G2 cells. H2AX
phosphorylation was assessed 16 h after exposure to toxin
as this was the earliest time that we observed pH2AX in
HeLa cells. In a representative experiment, the wild-type
CdtB subunit induced an increase in the MCF of cells
stained with anti-pH2AX-fluorescein isothiocyanate to 81
vs 15 in untreated cells (Fig. 7E–H). Cumulative results
from multiple experiments demonstrated a statistically
significant increase in pH2AX fluorescence of 375% over
that observed in control cells (set at 100%). In contrast,
CdtBA163R had a marginal effect on pH2AX fluorescence,
raising the MCF in a representative experiment to 22.
Based upon multiple experiments, treatment of HeLa cells
with CdtBA163R resulted in a 37.3 ± 2.0% increase in pH2AX
© 2015 John Wiley & Sons Ltd, Cellular Microbiology, 18, 223–243

fluorescence over that observed in control cells; this
difference was not statistically significant. However, the
reduction in pH2AX fluorescence observed with CdtBA163R
versus CdtBWT was statistically significant (Fig. 7I). Likewise, CdtBR144A failed to induce pH2AX in HeLa cells;
these cells exhibited an MCF of 18 (Fig. 7H), and the
aggregate data indicate pH2AX fluorescence equivalent to
control cells (105 ± 8%). In summary, we show that the
CdtBA163R mutant, in which phosphatase and DNase
activities are decoupled, can induce G2 arrest without
causing DNA damage and further that the CdtBR144A
mutant, which exhibits reduced phosphatase and a
significant increase in DNase activity, is not able to induce
either G2 arrest or H2AX phosphorylation.
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and CdtB
on cell cycle and pH2AX in HeLa cells. HeLa cells were treated with medium
WT
A163R
R144A
alone (panels A and E), CdtA and CdtC in the presence of CdtB (panels B and F), CdtB
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experiments is shown in panel I; solid bars represent results of cell cycle analysis (%G2 cells), and hatched bars represent the mean channel
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In the last series of experiments, we explored the
possibility that Cdt alters PI-3K signalling in HeLa cells in a
manner similar to that observed with lymphoid cells. The
effect of the toxin was first assessed on PIP3 levels. As
shown in Fig. 8A, baseline levels of PIP3 in HeLa cells
was 4.5 ± 0.4 pmol per 106 cells; these values decreased
to 3.6 ± 0.6 and 3.2 ± 0.3 pmol per 106 cells at 4 h after
exposure to 5 and 50 ng ml 1 of Cdt. Increasing the toxin
concentration to 500 ng ml 1 did not cause a further
decline in PIP3 levels. Similar results were observed for
pGSK3β; in the presence of CdtBA163R and CdtBR144A,
phosphorylation of this kinase was reduced to 67% of

control values (Fig. S5). The ability of GSK inhibitor XV
was then tested for its ability to block cell cycle arrest
induced by both CdtBWT and CdtBA163R (Fig. 8B). HeLa
cells were treated with 25 ng ml 1 of CdtB peptide in the
presence of Cdt subunits A and C as described; cell cycle
distribution was assessed 24 h later. Exposure to CdtBWT
and CdtBA163R resulted in 77.7 ± 7.3 and 82.8 ± 4.4% G2
cells respectively. The addition of GSK inhibitor XV prior to
the addition of toxin blocked cell cycle arrest; the
percentage of G2 cells in the presence of inhibitor was
18.2 ± 2.4 (CdtBWT) and 20.5 ± 1.4% G2 (CdtBA163R).
Discussion
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Fig. 8. Effect of Cdt on PIP3 levels in HeLa cells and the ability of
GSK3β inhibitor to block toxicity. Panel A: HeLa cells were exposed to
Cdt holotoxin as indicated, harvested, PIs extracted and measured by
enzyme-linked immunosorbent assay. Bars represent mean ± SEM of
three experiments; the asterisk indicates statistical significance
(p < 0.05) when compared with untreated control cells. Panel B: HeLa
1
WT
cells were exposed to medium alone, 25 ng ml CdtB or
A163R
1
CdtB
(in the presence of 25 ng ml of each CdtA and CdtC)
alone or toxin in the presence the GSK inhibitor XV. Cell were
analysed for cell cycle distribution 24 h later. The mean ± SEM for the
percent of G2 cells is plotted; the asterisk indicates statistical
significance (p < 0.05) when compared respectively with cells treated
WT
A163R
with either CdtB or CdtB
.

There is general agreement that exposure of susceptible
target cells to Cdt holotoxin leads to irreversible G2 arrest
and eventually apoptosis (Gelfanova et al., 1999; CortesBratti et al., 2001b; Shenker et al., 2001; Ohara et al.,
2004). However, the nature of the early events leading to
toxicity is not clear and are likely dependent upon the
underlying molecular mechanism(s) by which the active
Cdt subunit, CdtB, interacts with subcellular targets. In this
regard, the Cdt holotoxin was recently crystallized and
analysed by X-ray crystallography (Nesic et al., 2004;
Yamada et al., 2006). Analysis reveals that CdtB exhibits
structural similarity with a group of functionally unrelated
metalloenzymes, which includes IP5P and DNase I,
among others. Despite the lack of significant pairwise
sequence identity, structural similarity was predicted on
the basis of sensitive multiple sequence alignments as an
extension of an earlier discovery of homology between the
nucleases and bacterial sphingomyelinase (Tsujishita
et al., 2001). Analysis of CdtB indicates that its structure
can be superimposed on IP5P with a root mean-square
deviation (RMSD) of 3.5 Å over 183 Cα atoms; this
compares with a structural overlap of CdtB with DNase I
with an RMSD of 3.1 Å over 207 Cα atoms (Shenker et al.,
2007). The bias in the literature towards rationalizing CdtB
function was initially partially based on structural homology with DNase I and has obscured the fact that its protein
fold, and most likely the reaction mechanism, is also
shared with many proteins within the superfamily of
metalloenzymes (Dlakic, 2000; 2001). Indeed, both
DNase I and IP5P are phosphoesterases, and it is likely
that the specific function of each of these enzymes is
dependent upon the substrate(s) that can be accommodated within the active site. Thus, it was not surprising that
we were able to demonstrate that CdtB exhibits robust
PIP3 phosphatase activity (Shenker et al., 2007).
To further explore the role of PIP3 phosphatase activity
in Cdt-mediated toxicity, we extended our studies to
include CdtB mutants of residues that we predict to be
associated with the active site and likely to be involved in
substrate binding: R117, R144 and A163 (summarized in
© 2015 John Wiley & Sons Ltd, Cellular Microbiology, 18, 223–243
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Table 2). Docking analysis using IP3 as a substrate
suggested that R144 forms a hydrogen bond with either
the C4 or C5 phosphate, which led us to predict that
mutation of the arginine to alanine would reduce phosphatase activity while not altering DNase activity. Indeed,
the CdtBR144A mutant exhibited reduced PIP3 phosphatase activity and cytotoxicity while DNase activity increased more than fourfold. Moreover, mutation of this site
to bulky residues such as tyrosine or lysine (R144Y and
R144K) rather than the small alanine resulted in the loss of
DNase activity; this is consistent with a reduction of space
available to accommodate DNA binding (data not shown).
We previously reported that CdtBR117A exhibits loss of
DNase activity as well as toxicity (Shenker et al., 2011),
and now we demonstrate decreased phosphatase activity
for this mutant. Our docking analysis suggests that R117
interacts with C3 phosphate of IP3 consistent with our
failure to detect any product with the CdtBR117A mutant
(Shenker et al., 2007). The A163 residue was predicted to
be involved in substrate binding, and we expected that
mutation of this residue would result in a change in inositol
phosphate specificity. We did not observe a change in
specificity and observed a modest, but not statistically
significant, reduction in phosphatase activity and concomitant decline in toxicity; in contrast, DNase activity was
significantly reduced to levels that were not detectable.
N201 is a residue found among the catalytic residues and
is conserved in all of the metalloenzymes in this family
(Dlakic, 2000); this amino acid was mutagenized along
with our predicted substrate-binding residues primarily to
provide comparison with previous studies (Nesic et al.,
2004). Our studies indicate that in addition to the loss of
both phosphatase and DNase enzymatic activity, the
CdtBN201A mutant also lost the ability to induce cell cycle
arrest as we observed a minor increase in G2 cells at the
highest concentration tested for this mutant (200 ng ml 1)
(Tsujishita et al., 2001). Lastly, a combination of R117,
R144 and N201 mutants was the same as reported by
Nesic et al. (2004); these authors showed that the triple
binding mutant, CdtBR117A•R144A•N201A, lost toxicity but
retained DNase activity. Our observations are similar as

Table 2. Summary of CdtB mutant activity.
DNase
activitya

CdtB mutant
R117A

CdtB
R144A
CdtB
A163R
CdtB
N201A
CdtB
R117A•R144A•N201A
CdtB
F156I•T158A•A163R
CdtB
Y239R
CdtB
Y239R•A240I•D244G•H246L
CdtB
a

Unchanged
↑
↓
↓
↑
↑
Unchanged
↑

PIPase
activitya
↓
↓
Unchanged
↓
↓
↓
↓
↓

Toxicitya
↓
↓
Unchanged
↓
↓
↓
↓
↓

WT

Activity is relative to CdtB

.
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this triple mutant lost toxicity and further lost PIP3
phosphatase activity. It should be noted that in our hands
this mutant not only retained DNase activity as reported by
Nesic et al. (2004) but also exhibited a threefold increase
over that observed with CdtBWT. Therefore, our results
confirm in a qualitative sense previous observations by
Nesic et al. (2004) and extend them by linking the loss of
CdtB mutant toxicity to the loss of phosphatase activity,
which we believe is the primary activity of CdtB.
Additional residues were targeted for mutation based on
the following two criteria: (1) proximity to CdtB catalytic
residues (in particular H160 and D238) as we tried to
increase the likelihood that they are part of the substratebinding active site and (2) residues that are either
conserved in both CdtB and IP5P but not in DNase I or
residues that are conserved in IP5P and DNase I but not
in CdtB (in both cases, CdtB residues were mutated into
corresponding DNase I residues). Our rationale was that if
PIP3 phosphatase was the main function of CdtB, making
CdtB mutants that resemble DNase I would improve its
DNase I activity while impairing its PIP3 phosphatase and
cytotoxicity. There are several residues close to catalytic
H160 that are conserved in CdtB and IP5P but not DNase
I. The double mutant, CdtBF156I•T158A, converted residues
to those found in DNase I; as predicted, this mutant
exhibited almost a doubling of DNase activity as well as
decreases in both toxicity and PIP3 phosphatase activity.
Introducing a third mutation, CdtBF156I•T158A•A163R, yields a
mutant protein with greater DNase activity, reduced
phosphatase and toxic activities. The last group of
mutations involved changing residues close to catalytic
D238 that were common to both IP5P and DNase I (Y239,
D244, H246 and A240); these were again mutated into
corresponding residues of DNase I. The first of these,
CdtBY239R, is positioned some distance away from the
presumed binding site according to our docking analysis.
We predicted that this mutation should not affect the
catalytic pocket; this was true for DNase activity; however,
both phosphatase and toxic activities were reduced,
suggesting that this residue must be important for CdtB
function. Two additional double mutants were generated
involving replacement of residues in CdtB to those
conserved in both DNase and IP5P. Again, our expectation was that phosphatase activity and toxicity would be
reduced and DNase activity elevated. However,
CdtBY239R•A240I and CdtBD244G•H246L exhibited a loss in
all three activities (data not shown). Interestingly, all four
mutations were combined into a single protein,
CdtBY239RA240ID244GH246L, which resulted in a loss in both
PIP3 phosphatase activity and toxicity while DNase
activity was increased over that observed with CdtBWT.
Mutation analyses clearly demonstrate that Cdt
immunotoxicity and PIP3 phosphatase activity correlated
qualitatively for all mutants tested, whereas DNase activity
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correlates with toxicity only for the catalytic N201 mutant
(summarized in Table 2). As the crystal structure of CdtB is
known, we have based our study on specific residues that
we predicted would affect substrate binding rather than
protein structure. For example, R117, R144 and A163
residues are part of the binding site based upon docking
analysis (supporting information). Thus, we are reasonably
confident that these mutants are not disrupting the
hydrophobic core of CdtB, as all these residues are close
to the surface and are unlikely to be important for protein
packing and its structural integrity. For the remaining
residues that were mutated, we cannot completely exclude
the possibility that some mutants may affect protein
stability. Yet our speculation is that these mutations are
not structurally compromising the protein for two reasons:
(1) the mutations were performed to substitute for residues
that are already present in related proteins such as DNase
I; and (2) whatever the effect of these mutations, it is
unlikely to be catastrophic in structural terms because most
of them improve DNase I activity and diminish only the
phosphatase activity of the resulting mutant protein, which
was our rationale for introducing them in the first place.
Taken as a whole, our mutagenesis studies yield two
clear conclusions: (1) all mutants diminish PIP3 phosphatase activity of CdtB to some degree, which is to be
expected if this is its main enzymatic function; and (2) the
majority of mutants improve DNase activity without
improving its cytotoxicity, indicating that DNase function
of CdtB is secondary. Given the differences between DNA
and lipid phosphates in terms of sizes and overall
structures, it stands to reason that they will never be
equally good enzymatic substrates for any single enzyme.
At the same time, both molecules have phosphate esters
among their functional groups and likely can be hydrolysed to at least some extent by many enzymes that
belong to the same superfamily as CdtB and DNase I
(Dlakic, 2000). Unlike mutation of catalytic residues, which
typically abolish both PIP3 phosphatase and DNase
activity (Shenker et al., 2007), we identified mutations in
non-catalytic residues that reduce the potency of CdtB as
a phosphatase while increasing its DNase activity. It
should be noted, however, that a single mutation cannot
completely switch enzyme specificity between two different substrates. Therefore, the R144A mutant with >400%
nuclease activity of the wild-type CdtB and only ~25% of
the wild-type CdtB PIP3 phosphatase activity is, in relative
terms, still much better as phosphatase than nuclease.
We speculate that similar mutations can be made in
DNase I that would reduce its nuclease activity while
improving its ability to hydrolyse other phosphate esters.
Consistent with the mutation results are our observations that the PI-3K/PIP3/Akt signalling pathway is
perturbed by CdtB. Evidence of perturbation of this
signalling pathway is supported by our observation that

within the first 2 h of exposure to toxin, Jurkat cells exhibit
a decline in substrate, PIP3, levels and a concomitant
increase in enzymatic product, PI-3,4-P2. Likewise, the
toxin was able to block mitogen-induced elevations of
PIP3 in HPBMC. Immediately downstream of PIP3 is the
critical kinase, Akt, which is normally phosphorylated and
activated as a result of PI-3K stimulation and elevations in
PIP3. Cdt-mediated depletion of PIP3 was accompanied
by a decrease in pAkt, which was both time and dose
dependent (the latter not shown); these changes were
demonstrated by both Western blot and flow cytometry
and confirmed by demonstrating a concomitant decrease
in kinase activity.
In addition to changes in Akt phosphorylation, we also
observed a reduction in the phosphorylation of the
downstream target of pAkt, GSK3β. In contrast to Akt,
de-phosphorylation of GSK3β results in a concomitant
increase in its kinase activity. GSK3β is a serine/threonine
kinase that was initially discovered as an inhibitor of
glycogen synthase but has also been implicated in the
regulation of inflammation, cell proliferation and apoptosis,
among others (Luo, 2009; Rayasam et al., 2009). Thus,
our observation that GSK3β inhibitors were able to reduce
both Jurkat cell and HPBMC susceptibility to Cdt-induced
G2 arrest is consistent with the known effects of PI-3K
signalling blockade in general, and GSK3β in particular, in
regulating cell growth (Buckler et al., 2008; Yuan and
Cantley, 2008; Huang and Sauer, 2010).
It should be noted that several investigators have
suggested that CdtB functions as a DNase, thereby
causing DNA degradation leading to activation of the
DDR, G2 checkpoint and cell cycle arrest (Lara-Tejero
and Galan, 2000; Cortes-Bratti et al., 2001b; Frisk et al.,
2001; Frisan et al., 2003) (Cortes-Bratti et al., 2001a; Li
et al., 2002; Guerra et al., 2008). These effects were
observed in a number of cell lines exposed to relatively
high concentrations of Cdt, up to 20 μg ml 1, and include
HeLa cells, HEp-2 cells, CHO cells and keratinocytes,
among others. Additional evidence for DNase activity in
CdtB mode of action is based upon this subunit’s ability to
denature or relax supercoiled plasmid DNA in vitro (Elwell
and Dreyfus, 2000; Elwell et al., 2001; Mao and DiRienzo,
2002; Frisan et al., 2003; Nesic et al., 2004). Interestingly,
we and others have demonstrated that CdtB exhibits very
low DNase activity relative to bovine DNase I (<0.01%;
Elwell and Dreyfus, 2000; Shenker et al., 2001; Nesic
et al., 2004), perhaps explaining the requirement for high
doses of toxin to induce DNA strand breaks. Additionally,
several of the earlier studies did not discriminate between
direct DNase activity associated with Cdt and the
possibility of indirect effects whereby toxin treatment
leads to activation of endogenous DNase. Indeed, our
own studies on lymphocytes support the notion that the
DNA fragmentation we and others have reported in
© 2015 John Wiley & Sons Ltd, Cellular Microbiology, 18, 223–243
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association with exposure of Cdt results from activation of
the apoptotic cascade (Gelfanova et al., 1999; Shenker
et al., 2001; Nalbant et al., 2003; Thelastam and Frisan,
2004). Nonetheless, we investigated the possibility that
the DDR was also activated in lymphoid cells under
conditions of low toxin concentration. For these studies,
we employed another lymphoid cell line, CCRF-CEM; we
determined that the optimal dose of Cdt for G2 arrest at
16 h was 200 pg ml 1. Under these conditions, we failed to
detect H2AX phosphorylation at 4 h of exposure while
treatment with a known DDR activator, etoposide, caused
significant increases in pH2AX. Moreover, the use of ATM
inhibitors (KU60019 and KU55933) failed to alter Cdtinduced G2 arrest, whereas cell cycle arrest and H2AX
phosphorylation due to etoposide exposure were reduced
by these inhibitors. Clearly, these results do not support
the role for activation of the DDR in association with Cdtmediated toxicity of lymphoid cells.
In order to determine if the lipid phosphatase activity
associated with CdtB and the resultant PI-3K blockade also
contributed to toxicity in non-lymphoid cells, HeLa cells, a
well-established experimental target cell to study the
actions of Cdt, were examined. Under conditions optimized
to induce cell cycle arrest at 24 h (25 ng ml 1 of each of the
Cdt subunits), we observed significant phosphorylation of
H2AX at 16 h in the presence of CdtBWT. In contrast, when
the wild-type protein was substituted with CdtBA163R, the
mutant retaining significant phosphatase but lacking
DNase activity, we failed to detect a significant increase
in pH2AX. It should be noted that this mutant did induce G2
arrest at levels comparable with those of CdtBWT. Thus,
HeLa cells were able to undergo Cdt-induced G2 arrest in
the absence of CdtB-associated DNase activity and
detectable DDR activation. These results are consistent
with those of Sert et al. (1999) who demonstrated that Cdtinduced G2 arrest in HeLa cells was independent of DNA
damage. We also examined other CdtB mutants that
retained DNase activity but exhibited significantly reduced
phosphatase activity; these were not able to induce cell
cycle arrest or increases in pH2AX in HeLa cells. In addition
to reductions in PIP3 and pGSK3β, further evidence for the
role of PI-3K blockade was demonstrated by the ability of
the GSK Inhibitor XV to block toxin-induced G2 arrest in
HeLa cells as observed for lymphoid cells. One feature of
Cdt’s effect on HeLa cells that differs from lymphoid cells is
the extent of PIP3 depletion. In the case of lymphoid cells,
PIP3 levels were reduced to 70–80% in the presence of 20–
5000 pg ml 1 quantities of toxin; in contrast, HeLa cells
required 5–50 ng ml 1 of toxin to achieve a smaller
reduction (30%). It is interesting to note that the level of
reduction observed for pGSK3β in HeLa cells mirrored the
effects observed for PIP3. This difference in PIP3 depletion
may contribute to the requirement for higher doses of Cdt
required to intoxicate HeLa cells as reported by several
© 2015 John Wiley & Sons Ltd, Cellular Microbiology, 18, 223–243
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investigators (Deng et al., 2001; Li et al., 2002; Guerra et al.,
2011). One possible explanation, suggested by several
investigators, is that PI-3K is constitutively active in HeLa
cells (Kang et al., 2012; Jin et al., 2014). In contrast,
lymphocytes typically exhibit low levels of PI-3K activity
with transient increases upon activation; moreover, the
sustained elevated levels of PIP3 in Jurkat cells result from
deficiencies in its degradation attributed to decreased
expression of both PIP3 phosphatases: PTEN and SHIP1
(Seminario et al., 2003; Shan et al., 2010).
Our results do not, however, rule out the possible
influence of DNase activity under conditions of exposure
to high concentrations of toxin for different periods of time
as reported by other investigators (Deng et al., 2001; Li
et al., 2002; Guerra et al., 2011). Moreover, it is becoming
increasingly clear that all cell types susceptible to Cdt do
not respond to the toxin in the same manner with some
cells rapidly becoming apoptotic and others arresting in
either the G1 or G2 phase of the cell cycle (Cortes-Bratti
et al., 2001b). Thus, it is possible that the underlying
cause of this variability, and the relative role of lipid
phosphatase versus DNase activity of CdtB, could be
determined by cell types and their relative dependence on
PI-3K signalling. For instance, Rabin et al. (2009) reported
that a CdtB mutant involving residue H160 (CdtBH160Q)
exhibited a decrease in PIP3 phosphatase activity and
reduced toxicity for proliferating cells but retained the
capacity to induce apoptosis in nonproliferating macrophages. It should be noted that these cells failed to exhibit
caspase activation and apoptosis-inducing factor release.
Thus, it is not clear if this represents a differential effect
involving proliferating versus nonproliferating cells or the
investigators’ failure to detect phosphatase activity because they were measuring substrate consumption as
opposed to the generation of enzymatic product. Indeed,
our own studies indicate that nonproliferating cells are not
susceptible to Cdt-induced apoptosis (Shenker et al.,
2001; 2010a; 2014). In other studies, Frisan et al. (2003)
suggest that PI-3K activation is required for the cellular
distension observed in Cdt-treated HeLa cells. Unfortunately, these authors did not provide direct evidence for
activation of the PI-3K cascade such as altered phosphorylation and activity of downstream targets. In this
context, it is also important to note that Lee et al. (2006)
demonstrated that while the regulation of cell size is
dependent upon PI-3K signalling and mammalian target of
rapamycin activation, there is a disconnect between cell
size regulation and the ability of cells to undergo cell cycle
arrest. These observations are particularly relevant to our
study as cellular distension is not a prominent feature of
Cdt-induced lymphocyte cell cycle arrest. Finally, it should
be noted that Saccharomyces cerevisiae are susceptible
to Cdt-induced cell cycle arrest (Hassane et al., 2001;
Matangkasombut et al., 2010). These observations are of
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interest as these cells do not produce PIP3; nonetheless,
they do produce, and are dependent upon, a myriad of
phosphatidylinositol monophosphate and diphosphates
for several functions including growth and survival
(Gardocki et al., 2005; Strahl and Thorner, 2007). It is
possible that CdtB is capable of altering one or more of
these moieties in S. cerevisiae, although it should be
noted that we have not observed such effects in lymphoid
cells or in a cell-free system.
Collectively, our observations support a critical role for
the lipid phosphatase activity associated with CdtB in
mediating G2 arrest. Several lines of evidence support the
candidacy of PIP3 as the primary molecular target of
CdtB, particularly in lymphoid cells and possibly in HeLa
cells as well. First, as previously noted, CdtB’s in vitro
PIP3 phosphatase activity is much more robust than its
nuclease activity (Shenker et al., 2007). Second, it
appears that the ability of CdtB and its mutants to induce
cell toxicity always correlates with retention of relatively
high levels of phosphatase activity and not DNase activity.
The CdtBA163R mutant, in particular, retains the ability to
induce G2 arrest even though it fails to stimulate DNA
damage. Finally, we have now demonstrated that cells
exposed to Cdt exhibit downstream changes consistent
with the action of a PIP3 phosphatase: decreases in PIP3,
increases in PI-3,4P2 and decreased phosphorylation of
Akt and GSK3β leading to a respective loss and gain of
kinase activity. The observations of Carette et al. (2009)
support, albeit indirectly, the role of CdtB in cell signalling
and lipid metabolism as these results are much easier to
explain in the context of PIP3 phosphatase activity of CdtB.
Nonetheless, our studies do not eliminate the possibility
that Cdt may indeed exhibit dual enzymatic functions.
DNase activity of CdtB may contribute to toxicity in some
cell types that do not employ PIP3 signalling, particularly
when exposed to high doses of toxin, while lipid phosphatase activity is critical for toxicity in other cells such as
lymphocytes that rely heavily on PIP3 signalling.
Experimental procedures

buoyant density centrifugation on Ficoll-Paque (Amersham
6

Pharmacia Biotech; Piscataway, NJ). Lymphocytes (1 × 10 cells
1

per millilitre) were activated with 1 μg ml PHA (Abbott Laboratories, Chicago, IL) following pre-treatment for 45 min with Cdt;
the cells were incubated in RPMI-1640, antibiotics and 2% heatinactivated human AB sera for the periods of time indicated.
HeLa cells (CRL-1958; ATCC) were cultured in minimal
essential medium supplemented with 10% foetal bovine serum
and 2% antibiotic solution at 37°C in 5% CO2. The cells were
5
seeded at 2 × 10 cells per well in a 12-well plate and allowed to
attach 1 day prior to experimental treatment. Following the
exposure, cells were trypsinized and analysed as described in
the following.
To measure Cdt-induced cell cycle arrest, cells were incubated for
the times indicated and then washed and fixed for 60 min with cold
80% ethanol (Shenker et al., 2005). The cells were stained with
10 μg ml

1

of propidium iodide containing 1 mg ml

1

of RNase

(Sigma-Aldrich, St. Louis, MO) for 30 min. Samples were analysed
on a Becton-Dickinson LSRII flow cytometer (BD Biosciences,
Franklin Lakes, NJ) as previously described (Shenker et al., 2005). A
minimum of 15 000 events were collected for each sample; cell cycle
analysis was performed using Modfit (Verity Software House,
Topsham, ME).
To measure pH2AX, cells were incubated with the toxin for 4 h
(Jurkat cells) or 16 h (HeLa cells), collected and fixed with 4%
paraformaldehyde in phosphate-buffered saline (PBS) for 30 min
at room temperature. Cells were washed, permeabilized (0.3%
Triton X-100) and blocked [PBS containing 1% bovine serum
albumin (BSA)] for 1 h at room temperature. Cells were stained
with pH2AX (S139) rabbit monoclonal antibody conjugated to
Alexa Fluor 488 (Cell Signaling Technology, Danvers, MA) in PBS
containing 1% BSA and 0.3% Triton X-100 overnight at 4°C.
Control samples were incubated with rabbit IgG isotype control
(Cell Signaling Technology). After washing, cells were analysed
by flow cytometry as described earlier.

Construction of plasmid containing CdtB mutant genes
Amino acid substitutions were introduced into the cdtB gene by
in vitro site-directed mutagenesis using oligonucleotide primer
pairs containing appropriate base changes (Table 1). Site-directed

Cell culture, cell cycle and phospho-H2AX analysis

mutagenesis was performed using the QuikChange II site-directed
mutagenesis kit (Stratagene, La Jolla, CA) according to the

The human leukaemic T cell line, Jurkat (E6-1), was maintained in

manufacturer’s directions. Amplification of the mutant plasmid

RPMI-1640 supplemented with 10% foetal calf serum, 2 mM of
1
of penicillin and
glutamine, 10 mM of HEPES, 100 U ml

was carried out using PfuUltra HF DNA polymerase (Stratagene).
All mutants involving a single amino acid utilized pGEMCdtB as a

100 μg ml

1

of streptomycin. Cells were harvested in mid-log growth
5

template; construction and characterization of this plasmid were
R117A•R144A•N201A

phase and plated at 5 × 10 cells per millilitre, or as indicated, in
24-well tissue culture plates. Cells were exposed to medium, Cdt

previously described (Shenker et al., 2005). pGEMCdtB
was achieved by first constructing a double-mutant-containing

peptides or Cdt holotoxin and incubated for times indicated.

plasmid, pGEMCdtB

Human peripheral blood mononuclear cells lymphocytes were
prepared as described previously (Shenker et al., 1982a). Briefly,

template (Shenker et al., 2007) and primers P3 and P4 (Table 1)
R144A
; the double mutant was then used as a
for pGEMCdtB

HPBMC were isolated from 100 to 200 ml of heparinized venous

template to construct pGEMCdtB

blood obtained from healthy donors. HPBMC were isolated by

P8. The triple-mutant-containing plasmid pGEMCdtB

R117A•R144A

, using pGEMCdtB

R117A•R144A•N201A

R117A

as a

with primers P7 and
F156I•T158A•A163R

© 2015 John Wiley & Sons Ltd, Cellular Microbiology, 18, 223–243
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was constructed using pGEMCdtB

as a template, along with

electrophoresis in Tris–borate–EDTA buffer; gels were stained

Y239R•A240I•D244G•H246L

with ethidium bromide and analysed by digital scanning densitom-

primers P9 and P10. Finally, pGEMCdtB

Y239R•A240I

was achieved by first constructing pGEMCdtB
with
primers P3 and P4 using pGEMCdtB as a template; the resulting
pGEMCdtB

Y239R•A240I

239

plasmid was then used as a template in

conjunction with primers P15 and P16. All mutants were verified by
DNA sequencing.

etry.

Measurement of cellular PIP3, PI-3,4-P2 and PI-3,5-P2
content
6

1

Cells (1 × 10 ml ) were incubated in the presence of medium or
7

Expression and puriﬁcation of Cdt peptides, CdtB mutants
and Cdt holotoxin

Cdt for 0–240 min. Replicate cultures (0.5–1 × 10 cells) were
pooled and harvested. The cell pellet was treated with cold 0.5
trichloroacetic acid (TCA) for 5 min and centrifuged and the pellet

In vitro expression of Cdt peptides and CdtB mutants was performed

washed twice with 5% TCA containing 1 mM of EDTA. Neutral

using the Rapid Translation System (RTS 500 ProteoMaster; Roche
Diagnostics Corp, Indianapolis, IN) as previously described (Shenker

lipids were extracted twice with methanol : chloroform (2:1) at room
temperature (RT). Acidic lipids were extracted with methanol :

et al., 2005). Reactions were run according to the manufacturer’s

chloroform : 12M HCl (80:40:1) for 15 min at RT; the samples were

specification (Roche Diagnostics Corp) using 10–15 μg of template
DNA. After 20 h at 30°C, the reaction mix was removed, and the

centrifuged for 5 min and the supernatant recovered. The
supernatant was then treated with 0.75 ml of chloroform and

expressed Cdt peptides were purified by nickel affinity chromatog-

0.1 M of HCl and centrifuged to separate organic and aqueous

raphy as described (Shenker et al., 2005).
Construction and expression of the plasmid containing the cdt

phases; the organic phase was collected and dried. The dried lipids
were resuspended in 120 μl of 50 mM HEPES buffer (pH 7.4)

his

genes for the holotoxin (pUCAacdtABC ) have previously been

containing 150 mM of NaCl and 1.5% sodium cholate and left

reported (Shenker et al., 2004). The plasmid was constructed so
that cdt genes were under control of the lac promoter and

overnight at 4°C. PI-3,4,5-P3, PI-3,4-P2 and PI-4,5-P2 levels were
then determined using commercially available competitive

transformed into E. coli DH5α. Cultures of transformed E. coli

enzyme-linked immunosorbent assay according to the manufac-

were grown in 1L LB broth and induced with 0.1 mM of isopropyl
β-D-1-thiogalactopyranoside for 2 h; bacterial cells were harvest-

turer’s directions (Echelon Biosciences).

ed, washed and resuspended in 50 mM of Tris (pH 8.0). The cells

Docking experiments

were frozen overnight, thawed and sonicated. The histidinetagged peptide holotoxin was isolated by nickel affinity chroma-

Docking experiments were performed using AutoDock and
analysed with AutoDockTools (Morris et al., 2009). Both IP3

tography as previously described (Shenker et al., 2000).

and IP2 were tested as ligands. After adding hydrogens to CdtB

Phosphatase assay

(pdb code 2f2f, chain B) and the ligand, we performed docking
where most of the protein was held rigid. The ligand was allowed

Phosphatase activity was assessed by monitoring the dephos-

to be flexible, as well as 15 amino acids in a radius of 8 Å around

phorylation of PIP3 as previously described (Maehama et al.,
2000; Shenker et al., 2007). Briefly, the reaction mixture (20 μl)

His274 (the presumed active site of CdtB). We typically recorded
500–1000 docking conformations, and the ligands from lowest-

consisted of 100 mM of Tris-HCl (pH 8.0), 10 mM of dithiothreitol,

energy complexes were clustered and visualized either with

0.5 mM of diC16-phosphatidylserine (Avanti Polar Lipids,
Alabaster, AL), 25 μM of PIP3 (Echelon Biosciences, Salt Lake

AutoDockTools or PyMol (PyMol Graphics System, Schrödinger,
LLC, New York, NY). Representative docking simulations are

WT

or mutant. Appropriate

shown in Figs. S1 and S2; these results helped us identify amino

amounts of lipid solutions were deposited in 1.5 ml tubes, organic
solvent removed, the buffer added and a lipid suspension formed by

acids that are potentially involved in substrate binding. This
information was used as a guide in our mutagenesis experiments.

City, UT) and the indicated amount of CdtB

sonication. Phosphatase assays were carried out at 37°C for 30 min;
the reactions were terminated by the addition of 15 μl of 100 mM
N-ethylmaleimide. Inorganic phosphate levels were then measured

Measurement of cellular content of Akt and GSK3β and
kinase activity

using a malachite green assay.

Cells were treated as described and solubilized in 20 mM of Tris-

DNase assay

HCl buffer (pH 7.5) containing 150 mM of NaCl, 1 mM of EDTA, 1%
NP-40, 1% sodium deoxycholate and protease inhibitor cocktail

CdtB peptides were assessed for DNase activity by monitoring

(ThermoFisher Scientiﬁc, Grand Island, NY). Samples (30 μg)

changes in electrophoretic mobility of supercoiled plasmid DNA as
described by Elwell and Dreyfus (2000). Briefly, supercoiled

were separated on 12% sodium dodecyl sulfate polyacrylamide gel
electrophoresis and then transferred to nitrocellulose. The mem-

pUC19 (1 μg per reaction) was incubated with CdtB, CdtB mutants

brane was blocked with BLOTTO and then incubated with one of

or bovine DNase I for 4 h at 37°C in a buffer containing 25 mM of
Hepes (pH 7.0), 10 mM of MgCl2 and 5 mM of CaCl2. The reaction

the following primary antibodies for 18 h at 4°C (Shenker et al.,
1999): anti-pAkt (S473), anti-pGSK3β (S9) (Cell Signaling Tech-

was stopped by adding 10 mM of EDTA (final concentration). The

nology) or anti-actin (Santa Cruz Biotechnology, Dallas, TX).

samples were then loaded onto 1% agarose gel and subjected to

Membranes were incubated with goat anti-mouse immunoglobulin
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conjugated to horseradish peroxidase (SouthernBiotech, Birmingham, AL). The Western blots were developed using chemiluminescence and analysed by digital densitometry (Kodak Image
Systems Rochester, NY) as previously described (Shenker et al.,
2010b).
6

Jurkat cells (2 × 10 ) were incubated for 2 h in the presence of
medium or Cdt as indicated. Cells were washed and fixed in 2%
formaldehyde and permeabilized using commercially available
fixative and permeabilization buffer (BD Biosciences). Cells were
then stained with anti-Akt conjugated to AF647 (BD Biosciences)
or with anti-pGSK3β (Ser9); the latter was detected with goat antirabbit antisera conjugated to fluorescein isothiocyanate (BD
Biosciences). Cells were then analysed by flow cytometry;
10 000 events were collected (Boesze-Battaglia et al., 2006).
Akt-specific and GSK3β-specific kinase activity was assessed in
6
control and Cdt-treated cells. Jurkat cells (2 × 10 ) were treated with
Cdt as described; replicate cultures pooled and solubilized. Akt activity
was measured using a commercially available assay kit (Cell Signaling
Technology). Briefly, Akt was immunoprecipitated, and the enzyme
was assessed for its ability to phosphorylate GSK3β in vitro; activity
was monitored by Western blot. GSK3β kinase activity was also
measured using a commercially available kit (Sigma-Aldrich). The
kinase was immunoprecipitated and activity determined by following
the utilization of

32

P-ATP to phosphorylate a synthetic substrate.

Statistical analysis
Mean ± standard error of the mean were calculated for replicate
experiments. Significance was determined using Student’s t-test; a
P-value of less than 0.05 was considered to be statistically significant.
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Supporting information
Additional Supporting Information may be found in the online
version of this article at the publisher's web-site:
Fig. S1. Lowest-energy clusters of IP2 (17 conformations) and
IP3 (21 conformations) are shown in panels A and C respectively.
A single lowest-energy docked conformation of IP2 and IP3 is
shown up close in panels B and D respectively. Ligand-interacting
amino acid residues mutated in our study (R117, R144 and A163)
are shown as light-blue sticks. Hydrogen bonds between amino
acids and the ligand are represented by magenta dashed lines.
Fig. S2. Docking simulations were performed as described in
Methods. The movie shows 500 different conformations of IP3
docked in the active site of CdtB.
Fig. S3. Effect of CdtB on pGSK3β levels in HPBMC. HPBMC
were activated with PHA in the presence of medium or Cdt
holotoxin (0–1000 pg ml−1) for 4 h; cells were then harvested,
fractionated by SDS-PAGE and analysed by Western blot for
pGSK3β, GSK3β and actin. Densitometry results are expressed
as a percentage of control cells (medium only) and are
represented by the numbers below each blot.
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WT

A163R

and CdtB

243

Fig. S4. Blockade of Cdt-induced G2 arrest in HPBMC by GSK3β

Fig. S5. Effect of CdtB

inhibitor. HPBMC were incubated with medium alone (panel A),

cells. HeLa cells were treated with 25 ng ml−1 of CdtB

on pGSK3β in HeLa
WT

or

A163R

PHA alone (panel B), PHA plus 200 pg ml−1 of Cdt holotoxin
(panel C) or PHA, Cdt holotoxin and GSK inhibitor X (50 μM) for

in the presence of 25 ng ml−1 of CdtA and CdtC for
CdtB
4 h. The cells were then harvested, solubilized, fractionated by

72 h. Cells were then stained with propidium iodide (PI) and

SDS-PAGE and analysed by Western blot for both pGSK3β (solid

analysed for cell cycle distribution; numbers represent the
percentage of G2 cells. This is a representative experiment of

bars) and GSK3β (cross-hatched bars). Results are expressed as
mean ± SEM relative intensity (% control) for three experiments;

three experiments each performed in triplicate.

the asterisk indicates statistical significance (p < 0.05).
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